Validation of the FIRST simplified frailty scale using the ECOG performance status instead of patient-reported activities
暂无分享,去创建一个
U. Mellqvist | P. Sonneveld | B. van der Holt | A. Waage | A. Dinmohamed | M. Levin | S. Zweegman | N. V. D. van de Donk | C. Stege
[1] M. Dimopoulos,et al. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial , 2019, Leukemia.
[2] U. Mellqvist,et al. Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma. , 2016, Blood.
[3] K. Anderson,et al. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: an International Myeloma Working Group report. , 2015, Blood.